delta(9-11)-tetrahydrocannabinol has been researched along with delta(9)-tetrahydrocannabinolic acid in 2 studies
| Studies (delta(9-11)-tetrahydrocannabinol) | Trials (delta(9-11)-tetrahydrocannabinol) | Recent Studies (post-2010) (delta(9-11)-tetrahydrocannabinol) | Studies (delta(9)-tetrahydrocannabinolic acid) | Trials (delta(9)-tetrahydrocannabinolic acid) | Recent Studies (post-2010) (delta(9)-tetrahydrocannabinolic acid) |
|---|---|---|---|---|---|
| 19 | 0 | 6 | 114 | 5 | 52 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clausen, F; Hassenberg, C; Hoffmann, G; Schürenkamp, J; Studer, A | 1 |
| Lazarus, P; Nasrin, S; Perez-Paramo, YX; Watson, CJW | 1 |
2 other study(ies) available for delta(9-11)-tetrahydrocannabinol and delta(9)-tetrahydrocannabinolic acid
| Article | Year |
|---|---|
Investigation of phase II metabolism of 11-hydroxy-Δ-9-tetrahydrocannabinol and metabolite verification by chemical synthesis of 11-hydroxy-Δ-9-tetrahydrocannabinol-glucuronide.
Topics: Chromatography, High Pressure Liquid; Dronabinol; Gas Chromatography-Mass Spectrometry; Glucuronides; Humans; Reference Standards | 2020 |
Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions.
Topics: Biotransformation; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dronabinol; Drug Interactions; Glucuronosyltransferase; HEK293 Cells; Hepatobiliary Elimination; Humans | 2021 |